H.C. Wainwright Reiterates Buy Rating on Stoke Therapeutics (STOK)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
| (NASDAQ: STOK) | Delayed: 25.46 +0.42 (1.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.04 | 52 Week High | $ | |||
| Open | $25.22 | 52 Week Low | $ | |||
| Day High | $25.52 | P/E | N/A | |||
| Day Low | $24.52 | EPS | $ | |||
| Volume | 3,182,098 | |||||
